David H. Abramson, MD; and Jasmine H. Francis, MD
January/February 2019—Management and treatment options for retinoblastoma have changed radically in recent decades.
Victor M. Villegas, MD; Aaron S. Gold, OD; and Timothy G. Murray, MD, MBA
November/December 2018—Targeted surgical ablation and use of personalized molecular genomics may lead to better outcomes.
Lin Liu, MD; Babak Masoomian, MD; and Carol L. Shields, MD
September 2018—Indocyanine green–enhanced transpupillary thermotherapy was an effective treatment for this patient.
Ariel Tyring, MD; Steven S. Saraf, MD; and Lisa C. Olmos de Koo, MD
July/August 2018—This viscous tamponade agent can be useful for complex retinal detachments, but it requires finesse.
José A. Roca, MD, and Natalia Alpízar-Alvarez, MD
July/August 2018—Management of this condition can be challenging, especially in chronic cases.
Timothy G. Murray, MD, MBA, FACS; Victor Villegas, MD; Aaron Gold, OD; Audina M. Berrocal, MD; and Ziad Khatib, MD
July/August 2018—A complex case presentation leads to a diagnosis of bilateral retinoblastoma.
Benjamin J. Thomas, MD; with Matthew A. Cunningham, MD
May/June 2018—The author finds that even short trips to provide care for underserved communities can have powerful effects.
Robin D. Ross, MD, MPH, CPH
May/June 2018—Building ophthalmic nursing capacity in Liberia after the Ebola epidemic of 2014-2016.
